Sporotrichosis

1. Overview
2. The Pathogen: Sporothrix schenckii
3. Epidemiology and the Brazil Epidemic
4. Transmission and Exposure Routes
5. Clinical Forms
6. Lymphocutaneous Sporotrichosis
7. Disseminated and Pulmonary Forms
8. Diagnosis
9. Treatment
10. Zoonotic Cat-Associated Sporotrichosis
11. Prevention and Prognosis
12. References
13. Connections
14. Featured Videos

Overview

Sporotrichosis is a subacute-to-chronic fungal infection caused by Sporothrix schenckii, a dimorphic fungus found in soil, decaying plant material, and on the surface of plants throughout the world. It is the most common subcutaneous mycosis in the developing world and classically presents as a chain of nodules ascending up the arm from a site of traumatic inoculation — a pattern called "lymphocutaneous sporotrichosis" or "sporotrichoid spread." The infection is nicknamed "rose gardener's disease" or "rose thorn disease" because thorn pricks from rose bushes are a well-known transmission route.

Most cases are mild and confined to the skin and lymphatics, making sporotrichosis treatable and rarely fatal in immunocompetent individuals. However, in immunocompromised patients — particularly those with HIV/AIDS or severe alcoholism — the fungus can disseminate to joints, bones, and the central nervous system, causing life-threatening infection.

A major public health development in the 21st century is the ongoing epidemic of cat-associated zoonotic sporotrichosis in Brazil, which has produced tens of thousands of cases and fundamentally changed the epidemiology of the disease.

Back to Table of Contents

The Pathogen: Sporothrix schenckii

Sporothrix schenckii is a thermally dimorphic fungus with two distinct growth forms depending on temperature:

• At ambient temperature (25–28°C), it grows as a mold with delicate branching hyphae and characteristic "flower-" or "daisy-" shaped clusters of conidia (spores) arranged around a central conidiophore — the "sleeves of conidia" arrangement is microscopically distinctive.
• At body temperature (37°C) in human tissue, it converts to a small, elongated yeast form described as "cigar-shaped" — a key diagnostic feature in histopathology.
• This thermal dimorphism is a hallmark of several pathogenic fungi (Histoplasma, Blastomyces, Coccidioides, Paracoccidioides) and represents adaptation to survive at human body temperature.

S. schenckii is found naturally in:

• Decaying plant material, bark, and vegetation
• Soil enriched with organic matter
• Thorns and splinters of plants (especially rose bushes, barberry bushes, bougainvillea, hay bales, sphagnum moss)
• The claws and skin lesions of infected cats (epidemic transmission route in Brazil)

Back to Table of Contents

Epidemiology and the Brazil Epidemic

Sporotrichosis is found worldwide but is most prevalent in tropical and subtropical regions with high organic matter in soil. Historical endemic areas include:

• Latin America: Brazil, Uruguay, Colombia, Peru, Mexico
• Asia: India, Japan, China
• Sub-Saharan Africa: South Africa
• North America: historically Midwestern and Southern United States (miners, agricultural workers)

The Brazil Epidemic (Rio de Janeiro, 1998–present)

The largest and most prolonged urban sporotrichosis outbreak ever documented began in the Greater Rio de Janeiro metropolitan area in the late 1990s and continues today. The epidemic is driven by zoonotic transmission from cats:

• Cats in the Rio area harbor high loads of S. schenckii in their skin lesions, nasal discharge, and claws.
• The fungus is transmitted to humans through bites, scratches, or direct contact with infected cats.
• By 2021, over 10,000 cat-associated human cases and thousands of feline cases had been documented in Rio de Janeiro alone.
• The epidemic has spread to other Brazilian states.
• Cat-associated sporotrichosis presents identically to soil-associated cases but can involve the face (from cat-scratch to the face) and can affect entire households.
• Veterinarians, cat rescuers, and shelter workers are at particularly high occupational risk.

Historically, the largest US outbreak was among Midwestern miners in the 1980s who handled contaminated sphagnum moss used to pack mine tunnels.

Back to Table of Contents

Transmission and Exposure Routes

Sporotrichosis reaches humans through several distinct pathways:

1. Traumatic inoculation (classic route): A thorn prick, wood splinter, or soil contact through a skin break introduces fungal spores into the dermis. Common exposures include rose gardening, bougainvillea gardening, handling hay or straw bales, working with sphagnum moss, landscaping, agricultural work, and forestry.
2. Cat scratch or bite (zoonotic): Cats with sporotrichosis carry high numbers of yeast in their lesions. A scratch or bite from an infected cat directly inoculates the fungus into the skin. This route is responsible for the Brazil epidemic and household clusters.
3. Inhalation (rare): Inhalation of conidia from contaminated dust can cause primary pulmonary sporotrichosis — a much rarer form that resembles tuberculosis. Miners and agricultural workers face the highest inhalation exposure risk.
4. Insect bites and animal contact (rare case reports): Armadillo contact in Latin America has been documented; armadillos can carry S. schenckii on their shell.

High-risk groups: florists, gardeners, farmers, forestry workers, veterinarians, cat shelter workers, miners, and immunocompromised individuals regardless of exposure type.

Back to Table of Contents

Clinical Forms

Sporotrichosis presents in several distinct clinical forms depending on the route of infection, the immune status of the host, and the inoculum size:

• Lymphocutaneous (70–80% of cases): The classic ascending nodule pattern. See dedicated section below.
• Fixed cutaneous (10–20%): A localized plaque or nodule at the inoculation site without proximal lymphangitic spread. More common in highly endemic regions, possibly due to partial immunity from prior exposure. The lesion may be warty, verrucous, or ulcerated. The face is a common site.
• Osteoarticular (5–10%): Usually in immunocompromised patients (alcoholism, HIV). Monoarticular arthritis of the knee, elbow, or wrist is most common. Can be chronic and destructive. May follow local inoculation or hematogenous dissemination.
• Disseminated: Multiple skin lesions at non-contiguous sites (more than two body regions), often with joint and bone involvement. CNS meningitis is rare but reported. Almost exclusively in HIV/AIDS patients, alcoholics, or severely immunosuppressed individuals.
• Pulmonary: Rare; results from inhalation of conidia. Upper lobe cavitary disease. Clinically and radiographically mimics tuberculosis. Disproportionately affects elderly men with COPD or alcoholism.
• Ocular: Sporadic keratitis after eye trauma with plant material.

Back to Table of Contents

Lymphocutaneous Sporotrichosis

This is the textbook presentation of sporotrichosis and accounts for the majority of all cases:

1. Initial nodule: One to four weeks after inoculation, a small painless or minimally tender nodule appears at the inoculation site — most often the hand or forearm from a thorn prick. The overlying skin may be red-purple. The nodule may ulcerate and form a chronic non-healing ulcer.
2. Lymphangitic spread: Over days to weeks, additional nodules appear along the lymphatic vessels draining the original site. They march proximally up the arm toward the elbow and then the axilla, producing a characteristic linear chain of nodules — the "sporotrichoid pattern."
3. Nodule behavior: Successive nodules may remain subcutaneous (fluctuant, mobile), ulcerate and discharge a clear or serosanguinous fluid, or spontaneously rupture and crust over — all while remaining largely painless. This lack of acute pain is the key clinical feature that distinguishes sporotrichosis from bacterial lymphangitis, which is acutely painful and fever-associated.
4. Sporotrichoid differential: Other infections can produce the same ascending lymphangitic nodule pattern. The differential is remembered as the "sporotrichoid differential": Nocardia brasiliensis, Sporothrix schenckii, Treponema (tularemia — Francisella tularensis), Mycobacterium marinum, and Leishmania brasiliensis.

The wrist and hand are the most common initial sites, reflecting the typical thorn-prick mechanism in gardeners. The face can be the primary site in zoonotic cat-scratch transmission.

Back to Table of Contents

Disseminated and Pulmonary Forms

Disseminated Sporotrichosis

Disseminated disease requires hematogenous spread from a primary skin or lung focus. Predisposing conditions include HIV/AIDS (particularly with CD4 count below 200 cells/μL), chronic high-dose alcohol use, solid organ transplantation, and hematologic malignancy.

• Clinical presentation: multiple non-contiguous skin nodules, joint involvement, possible CNS meningitis
• Diagnosis: culture of blood, CSF, or skin biopsy
• Treatment: amphotericin B (lipid formulation preferred) as induction therapy for 2–4 weeks, followed by prolonged itraconazole maintenance for 12 months or more
• Prognosis: poor without immune reconstitution in HIV-infected patients; outcomes improve dramatically with antiretroviral therapy (ART) combined with antifungal treatment

Pulmonary Sporotrichosis

Pulmonary sporotrichosis results from inhalation of conidia and presents as chronic progressive cavitary lung disease. The classic patient is an elderly male with heavy alcohol use and pre-existing COPD or silicosis.

• Imaging: upper lobe cavities, nodules, and infiltrates on chest X-ray or CT — radiographically identical to tuberculosis, histoplasmosis, and aspergillosis
• Diagnosis: sputum culture for S. schenckii, which may require repeated specimens given intermittent shedding
• Treatment: itraconazole for mild-to-moderate disease; amphotericin B induction for severe or progressive cases, with step-down to long-term itraconazole

Back to Table of Contents

Diagnosis

Culture (Gold Standard)

Tissue biopsy or aspirate of a nodule or ulcer is the most reliable specimen. Other specimens include sputum (pulmonary), CSF (meningitis), and blood (disseminated disease in HIV patients). Cultures are grown on Sabouraud's dextrose agar at 25–28°C, with growth appearing within 1–4 weeks. Classic mold morphology shows thin hyphae with the "daisy arrangement" of conidia at 25°C. Dimorphism is confirmed by subculturing at 37°C in enriched media, which produces cigar-shaped yeast forms. Sensitivity is approximately 70–80% from biopsy and lower from swabs of superficial ulcers.

Histopathology

Hematoxylin-eosin staining is supplemented with PAS (periodic acid-Schiff) and GMS (Grocott-Gomori methenamine silver) stains. Findings include small budding oval yeast forms (2–3 × 4–6 μm), often intracellular within macrophages. Importantly, the yeast are few in number in tissue — making them easy to miss. A negative histopathology does NOT rule out sporotrichosis.

The asteroid body — a single S. schenckii yeast surrounded by a star-shaped radial eosinophilic material (the Splendore-Hoeppli phenomenon) — is pathognomonic for sporotrichosis but is present in only approximately 30% of cases. When found, it is extremely helpful diagnostically. Background inflammation is granulomatous with giant cells, suppurative areas, and variable necrosis.

Serology

ELISA and tube agglutination tests detect IgG against S. schenckii cell wall antigens. These are used in Brazil as a standard diagnostic tool (Fiocruz laboratory) and are most useful in disseminated disease — where high antibody titers are present — and for monitoring treatment response (declining titers indicate improvement). Cross-reactivity with other fungi is possible. These tests are not widely available outside Brazil and Latin America.

Molecular/PCR

PCR-based methods are not yet standardized and are used primarily in research settings. They improve sensitivity in low-burden tissue specimens and may eventually become the standard for rapid diagnosis.

Clinical Diagnosis

The classic lymphocutaneous pattern combined with compatible exposure history and residence in or travel to an endemic region creates a high pre-test probability. Empirical treatment with itraconazole is reasonable while awaiting culture confirmation, which is inherently slow.

Back to Table of Contents

Treatment

Lymphocutaneous and Fixed Cutaneous (First-Line)

Itraconazole 200 mg once daily for 3–6 months is the current standard of care. Doses of 200 mg twice daily are used for fixed cutaneous forms or slow responders. The oral solution has better bioavailability than capsules; capsules should be taken with a fatty meal and an acidic beverage for best absorption. Response is typically slow (weeks to months); treatment success is judged by nodule resolution and absence of new lesions. Continue for at least 4 weeks after complete clinical resolution to prevent relapse.

Saturated Solution of Potassium Iodide (SSKI)

SSKI has been the primary treatment for sporotrichosis since 1903 — predating the antifungal azoles by nearly 80 years — and remains recommended by the WHO for resource-limited settings where itraconazole is unaffordable. Starting dose is 5 drops three times daily, escalating by 5 drops per day as tolerated to 40–50 drops three times daily. The mechanism is not fully understood but may be immunomodulatory plus direct antifungal. Adverse effects include metallic taste, salivary gland swelling (iodism), GI upset, and acneiform rash. It is contraindicated in thyroid disease and pregnancy. SSKI is effective for lymphocutaneous sporotrichosis but less reliable for fixed cutaneous or deeper infection.

Terbinafine

Terbinafine 500–1000 mg daily is an alternative to itraconazole. Slightly less evidence supports its use, but it is useful for itraconazole-intolerant patients or in pediatric patients (weight-based dosing). Standard course is 3–6 months.

Disseminated Sporotrichosis

• Amphotericin B (lipid complex, ABLC, or liposomal formulation — less nephrotoxic than conventional amphotericin) as induction therapy for 2–4 weeks
• Step-down to itraconazole 200 mg twice daily for a minimum of 12 months
• In HIV patients: concurrent antiretroviral therapy (ART) is essential; secondary prophylaxis with itraconazole 200 mg daily is continued until CD4 count exceeds 200 cells/μL for 12 months

Pulmonary Sporotrichosis

• Mild-to-moderate: itraconazole 200 mg twice daily for 12–18 months
• Severe: amphotericin B induction followed by long-term itraconazole
• Surgical resection for localized cavitary disease that fails medical therapy

Osteoarticular Sporotrichosis

• Itraconazole 200 mg twice daily for 12–24 months
• Surgical debridement or synovectomy for itraconazole-refractory joint disease

Pregnancy

All azole antifungals (itraconazole, fluconazole, voriconazole) are teratogenic and must be avoided during pregnancy. SSKI is also contraindicated due to risk of fetal hypothyroidism. Amphotericin B (conventional or lipid formulation) is the only option during pregnancy, with risks and benefits carefully discussed with the patient.

Back to Table of Contents

Zoonotic Cat-Associated Sporotrichosis

The Rio de Janeiro epidemic has fundamentally changed our understanding of sporotrichosis epidemiology. Cat-associated sporotrichosis is now recognized as a distinct and highly efficient transmission route with unique features.

Affected Cats

• Infected cats develop skin lesions (crusted nodules, non-healing wounds) particularly on the face, paws, and ears.
• Nasal secretions from infected cats often contain large numbers of S. schenckii yeast — much higher fungal burdens than are present in human lesions.
• Transmission from cat to human is highly efficient: a single scratch or bite from an infected cat is sufficient for inoculation.
• A single infected cat can transmit sporotrichosis to multiple family members within the same household.

Clinical Features in Humans

Cat-transmitted sporotrichosis can involve the face (nose, cheek, periorbital region) because cats often scratch at facial skin. Multiple simultaneous inoculation sites are possible after multi-scratch encounters. Otherwise the clinical presentation is identical to soil-associated cases — the same lymphocutaneous nodule chain, the same diagnostic tests, the same treatment protocols.

Management of Cat-Associated Cases

1. Treat the infected human: itraconazole as per standard guidelines above.
2. Identify and treat the infected cat: itraconazole 5–10 mg/kg/day; long treatment courses are required. Prognosis is good with treatment but recurrence is common in endemic areas.
3. Protective measures for cat owners: wear gloves when handling cats with skin lesions; clean any cat scratch or bite wound immediately with soap and water; seek medical evaluation if a skin nodule develops at a cat-contact site.
4. Veterinarians and shelter workers: universal precautions including gloves and mask when handling cats with suspicious skin lesions; maintain a high index of suspicion for occupational sporotrichosis.

Back to Table of Contents

Prevention and Prognosis

Prevention

• Wear gardening gloves when handling roses, cacti, barberry, bougainvillea, hay bales, and other plant material with thorns or spines.
• Protect any existing cuts or abrasions before gardening or soil contact.
• Wash wounds thoroughly with soap and water after any thorn or splinter injury.
• Veterinarians and cat owners should wear gloves and protective eyewear when handling cats with skin lesions.
• No vaccine is currently available; no chemoprophylaxis is recommended for exposed but asymptomatic individuals.

Prognosis by Clinical Form

• Lymphocutaneous: Excellent — over 90% cure rate with itraconazole.
• Fixed cutaneous: Good, though longer treatment courses are often needed.
• Osteoarticular: Fair — can become chronic; long treatment courses and surgical debridement are often required.
• Pulmonary: Variable — worse outcomes in patients with COPD or alcoholism; requires 12–18 months of azole therapy.
• Disseminated: Poor without immune reconstitution in HIV patients; outcomes improve dramatically with ART combined with antifungal treatment.
• Without treatment: Sporotrichosis rarely self-resolves. Most lymphocutaneous cases progress slowly over months to years without spontaneous cure.

Back to Table of Contents

References

1. de Lima Barros MB, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis. 2004;38(4):529–35. PMID 14765345
2. Chakrabarti A, et al. Sporotrichosis: evolving trends and treatment. Indian J Med Res. 2015;141(4):401–10. PMID 26044539
3. Kauffman CA, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(10):1255–65. PMID 17968818
4. Rex JH, Okhuysen PC. Sporothrix schenckii. In: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 2000. PMID 10719804
5. Rodrigues AM, de Hoog GS, Camargo ZP. Sporothrix species causing outbreaks in animals and humans driven by animal-animal transmission. PLoS Pathog. 2016;12(7):e1005638. PMID 27462895
6. Gutierrez-Galhardo MC, et al. Epidemiological aspects of sporotrichosis epidemic in Brazil. Curr Fungal Infect Rep. 2010;4(2):120–5. (Review, Springer)
7. Lopes-Bezerra LM, et al. Sporotrichosis in animals and humans: new perspectives. Mem Inst Oswaldo Cruz. 2006;101(Suppl 1):303–12. PMID 17308783
8. da Rosa AC, Scrofernecker ML, Vettorato R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52(3 Pt 1):451–9. PMID 15761424
9. Marimon R, et al. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45(10):3198–206. PMID 17686832
10. Schubach A, Barros MB, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis. 2008;21(2):129–33. PMID 18317029
11. Bonifaz A, et al. Sporotrichosis: an update. G Ital Dermatol Venereol. 2012;147(6):581–9. PMID 23149555
12. Sampaio FM, et al. Molecular diagnosis of sporotrichosis. J Clin Microbiol. 2022;60(3):e0126021. PMID 35014866

Back to Table of Contents

Connections

• Infectious Disease Hub
• Melioidosis
• Leptospirosis
• Strongyloidiasis
• Leishmaniasis
• Blastomycosis
• Histoplasmosis
• Dermatology
• Lab Tests

Back to Table of Contents

Featured Videos

Channel Name — Sporotrichosis: rose gardener's disease explained.

Channel Name — Sporothrix schenckii: dimorphic fungus and cigar-shaped yeast.

Channel Name — Lymphocutaneous sporotrichosis: the ascending nodule pattern.

Channel Name — The Brazil cat-associated sporotrichosis epidemic in Rio de Janeiro.

Channel Name — Diagnosing sporotrichosis: culture, histopathology, and asteroid bodies.

Channel Name — Itraconazole and SSKI: antifungal treatment for sporotrichosis.

Channel Name — Zoonotic fungal infections: protecting yourself from cat-scratch sporotrichosis.

Channel Name — Disseminated sporotrichosis in HIV: amphotericin B and immune reconstitution.

Channel Name — Pulmonary sporotrichosis: cavitary lung disease mimicking tuberculosis.

Channel Name — Subcutaneous mycoses: sporotrichosis and the developing world burden.

Channel Name — Dimorphic fungi: how Sporothrix switches between mold and yeast forms.

Channel Name — Gardening safety: preventing thorn-associated fungal and bacterial infections.

Channel Name — Sporotrichoid spread: the differential diagnosis of ascending lymphangitic nodules.

Channel Name — SSKI: 120 years of potassium iodide as an antifungal for sporotrichosis.

Channel Name — Feline sporotrichosis: diagnosis and treatment in cats during the Brazilian epidemic.

Channel Name — Clinical review: subcutaneous and systemic fungal infections in tropical medicine.